Rossum Robot Secures Over RMB 100 Million in Series B Funding to Advance Intelligent Surgical Robotics

VCBeat (WeChat: vcbeat) has learned that intelligent surgeryRobotDeveloper—Beijing Rossum Robot Technology Co., Ltd. (ROSSUM ROBOT), announced the completion of its Series B financing round exceeding RMB 100 million, led byBeijing Zhongguancun Science City Company, led by Shenzhen Capital Group (SCGC), with follow-on investments from Qingkong Investment Promotion Fund and Shengjing Capital. Life Capital served as the exclusive financial advisor.This round of financing will be primarily used to accelerate the R&D of new surgical robot products, clinical registration, production expansion, and global market promotion.

Rossum Robot was founded in 2017,As a product of the close integration of medical-engineering interdisciplinary collaboration between Beihang University and Beijing Jishuitan Hospital,Focus on HealthcareRobotPioneering Original Innovations in Cutting-Edge Technologies: Empowering Healthcare Institutions with Proprietary Medical RoboticsThe company is dedicated to developing a new generation of intelligent orthopedic surgical robot systems with fracture reduction capabilities. It has pioneered advanced technologies worldwide, including intraoperative real-time 3D navigation, assisted fracture reduction, and automated surgical planning, thereby enabling intelligent surgical operations throughout the entire procedure—from closed fracture reduction to minimally invasive fixation—to meet the urgent needs of clinical treatment.

Closed reduction of pelvic fractures, recognized internationally as the most challenging surgical procedure in trauma orthopedics, has long been a formidable challenge that clinicians and engineers have jointly strived to overcome, yet without definitive success. The procedure fundamentally pushes against human physiological limits: on one hand, the highly complex three-dimensional anatomy of the pelvis is difficult to fully visualize through intraoperative fluoroscopy, posing a significant challenge to clinicians’ spatial imagination; on the other hand, closed reduction requires precise adjustments of position and orientation under high loads, while the human body struggles to simultaneously control speed and accurate displacement during force application, representing a longstanding pain point in clinical practice. AndRobotAs an extension of the human body, it can help humans overcome physiological limitations. Developed countries such as the United States, Japan, and Germany have conducted extensive research and development in this area, but no mature system has yet entered clinical application. The new generation of intelligent orthopedic surgical robot system developed by Rossum Robot, featuring fracture reduction capabilities, includes real-time 3D intraoperative navigation for fractures, computer-aided automatic planning, and autonomous robotic reduction operations. This achieves the goal of “leaving the most challenging tasks to the robot,” which is an inevitable trend in the development of surgical robots.

Rossum Robot chose to tackle international challenges, targeting the urgent clinical needs in both domestic and global markets, and filled the gap in fracture reductionRobotfilling an international gap and enabling Chinese-made technology to achieve leapfrog development.

Wang Yu, Founder of Rossum Robotstated: "We aim to leverage digital means to 'replicate' the extensive experience of clinical experts, thereby achieving personalized surgical planning. Relying on a robust R&D approach that integrates medicine and engineering, Rossum Robot aims to build a foundational general-purpose software and hardware platform with core competitiveness for future surgeries"Robot"This will follow a platform-based development path. Rossum Robot will build a clinical-need-driven product innovation system to support our future coverage of more clinical needs. The rapid development of robotic technology is changing the concepts and models in the medical field. As an indispensable tool for minimally invasive surgery, robotic systems have the potential to reduce total social healthcare costs and improve the accessibility of medical resources, representing the future direction of modern surgical technology."

BeijingZhongguancun Science CityInnovation Development Co., Ltd.General ManagerZhu Pingstated: "The reduction of pelvic fractures is a global challenge, with surgical procedures being extremely difficult, representing a typical unmet clinical need. Through continuous efforts to overcome these challenges, and leveraging the company team's excellent background in medical-engineering interdisciplinary collaboration, Rossum Robot has finally solved this global problem by successfully developing the world's first intelligent fracture reduction system."Robot, effectively addressing the lack of reduction capabilities in existing orthopedic surgical robots, while significantly improving the success rate of closed reduction surgeries for pelvic fractures, particularly fragility fractures in elderly patients. As the core area of Beijing’s International Science and Technology Innovation Center and a key hub for the capital’s “Four Centers” functions, Haidian District is committed to building a world-class innovation ecosystem, fostering more specialized, refined, distinctive, and innovative enterprises, and generating more internationally original hard-tech achievements, thereby contributing greater strength to the development of Beijing’s International Science and Technology Innovation Center. We are delighted to see high-quality projects like Rossum Robot emerge and grow in Haidian, and we are honored to participate in this round of the company’s financing.”

Shenzhen Capital Group Investment TeamIt is indicated that intelligence, digitalization, and minimally invasive techniques are the inevitable trends in the future development of surgery. Promoting the homogenization of medical services will further alleviate the uneven distribution of medical resources in China, return to the essence of healthcare, and demonstrate clinical value. Achieving benefits for patients, hospitals, and society is our ultimate goal. The intelligent orthopedic surgical systems developed by Rossum RobotRobotThis innovation has significantly enhanced the intelligence level of orthopedic surgical robots in China, filled a research gap in this field, and represents a global first. Shenzhen Capital Group will spare no effort in supporting the company’s steady development, with the expectation that the product will achieve faster adoption after its market launch, thereby benefiting more patients.

Shengjing CapitalPartnerMr. Li Zhihongstated: “SurgeryRobotIt is an inevitable trend in the development of surgical procedures, characterized by high R&D difficulty and significant technical barriers, requiring long-term technological accumulation and sustained investment. Rossum Robot’s fracture reduction surgical robot, designed for pelvic fracture surgeries—the most challenging procedures in orthopedic surgery—represents the direction of advanced productivity for the new generation of orthopedic surgical robots.

The investment team of Qingkong Investment Promotion Fund stated": "Medical-engineering integrationAI, sensors,RobotBy integrating these hard technologies with healthcare, intelligence and digitalization enable machines to learn surgeons’ skills and experience and deliver them consistently, simplifying complex procedures, minimizing invasiveness in major surgeries, and broadening access to medical resources. The intelligent pelvic reduction robot, jointly developed by Rossum Robot and Jishuitan Hospital, incorporates advanced technologies such as preoperative automated surgical planning, intraoperative real-time 3D visual navigation, and force–position collaborative precision control. It overcomes the traditional limitations of surgeons’ “brain,” “eyes,” and “hands,” making closed pelvic reduction surgery more precise, minimally invasive, and intelligent. In clinical trials, it has even successfully performed closed minimally invasive pelvic reduction surgery on a 92-year-old patient. As the product is rolled out for clinical use and broader adoption, it will help elevate the standard of fracture and trauma reduction treatment, replicate high-end surgical capabilities, enhance hospitals’ medical proficiency, and benefit a wide patient population. Qingkong Investment Fund was honored to participate in this funding round and will continue to closely monitor and support the company’s development.

As the exclusive financial advisor for this round,Director of Life CapitalGeneral ManagerSylvia Siustated: “Rossum Robot, as the world’s first pelvic fracture reductionRobot“With a market gap representing a blue ocean opportunity, Rossum Robot has iterated on existing positioning functionalities to create an intelligent surgical platform for reduction procedures, truly addressing the most critical and pressing clinical needs. Coupled with its decades of technical accumulation in the integration of medicine and engineering, Rossum Robot’s commercialization prospects are promising. We believe this robot will undoubtedly become a disruptive product that benefits humanity!”

In the future, Rossum Robot will continue to empower healthcare with technology, taking it as its mission to advance surgical treatment toward minimally invasive and intelligent solutions. By persisting in original innovation of cutting-edge technologies, Rossum Robot is committed to contributing to the development of China’s medical industry.